Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morning Review
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Insider Transactions
    • Transkriptioner
  • InderesTV
  • Portfölj
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • Om oss
    • Bolag under bevakning
    • Teamet
Regulatoriskt pressmeddelande

ADDvise announces financial update for 2025

ADDvise Group
Ladda ner börsmeddelandet

On 10 December 2025, Amplex AB (“Amplex” or the “Bidder”) announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) (“ADDvise” or the “Company”) to transfer all their shares and warrants in the Company to Amplex (the “Offer”).

To provide shareholders and warrant holders in ADDvise with the necessary information to make an informed decision regarding the Offer, the Company is today announcing certain preliminary financial information for the fourth quarter and full year 2025.

October–December 2025

Net revenue preliminarily amounted to SEK 422 million (442), an organic decrease of 4.5%, and an organic increase of 4.0% adjusted for currency effects.

EBITA preliminarily amounted to SEK 80 million (75), an increase of 6.7%.

January–December 2025

Net sales preliminarily amounted to SEK 1,605 million (1,671), an organic decrease of 3.9%, and an organic increase of 1.5% adjusted for currency effects.

EBITA preliminarily amounted to SEK 273 million (271), an increase of 0.7%.

ADDvise’s year-end report for 2025 will be published on February 12, 2026.

For more information, please contact:

Staffan Torstensson, CEO
+46 704 33 20 19
staffan.torstensson@addvisegroup.se

About ADDvise Group

ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 1.6 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the company’s Certified Adviser. More information is available at www.addvisegroup.com.

This information is information that ADDvise Group is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-14 16:50 CET.

Attachments
ADDvise announces financial update for 2025

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Ta kontakt
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.